These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 23803055
21. Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy. Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R. J Radiat Res; 2010; 51(4):465-71. PubMed ID: 20508373 [Abstract] [Full Text] [Related]
22. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic. Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu J, Wang Q, Chen G, Chen H, Xiang J, Fu X. Lung Cancer; 2013 Aug; 81(2):213-7. PubMed ID: 23664030 [Abstract] [Full Text] [Related]
23. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma? Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S. Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592 [Abstract] [Full Text] [Related]
24. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW. Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058 [Abstract] [Full Text] [Related]
25. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA. J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [Abstract] [Full Text] [Related]
26. Prognositc significance of SUVmax on pretreatment 18 F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: A meta-analysis. Dong M, Liu J, Sun X, Xing L. J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166 [Abstract] [Full Text] [Related]
27. Prognostic value of FDG uptake in early stage non-small cell lung cancer. Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, Poncelet AJ. Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589 [Abstract] [Full Text] [Related]
28. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT. Park B, Kim HK, Choi YS, Kim J, Zo JI, Choi JY, Shim YM. Korean J Radiol; 2015 May; 16(4):929-35. PubMed ID: 26175595 [Abstract] [Full Text] [Related]
29. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer]. Zhao SJ, Wu N, Zheng R, Liu Y, Zhang WJ, Liang Y, Zhang H, Li XM. Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097 [Abstract] [Full Text] [Related]
30. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer. Zhao F, Ding G, Huang W, Li M, Fu Z, Yang G, Kong L, Zhang Y, Yu J. Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696 [Abstract] [Full Text] [Related]
31. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. Um SW, Kim H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Choi JY, Han J, Lee KS, Kim J. J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106 [Abstract] [Full Text] [Related]
32. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT. Wang Y, Ma S, Dong M, Yao Y, Liu K, Zhou J. BMC Pulm Med; 2015 Mar 08; 15():20. PubMed ID: 25880540 [Abstract] [Full Text] [Related]
33. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer. Tong AN, Han SR, Yan P, Gong H, Zhao H, Yao H, Wang YM. Med Oncol; 2014 Jan 08; 31(1):780. PubMed ID: 24326983 [Abstract] [Full Text] [Related]
34. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N. Ann Nucl Med; 2009 Aug 08; 23(6):523-31. PubMed ID: 19444550 [Abstract] [Full Text] [Related]
35. Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer. Yıldırım F, Yurdakul AS, Özkaya S, Akdemir ÜÖ, Öztürk C. Clin Respir J; 2017 Sep 08; 11(5):602-611. PubMed ID: 26434685 [Abstract] [Full Text] [Related]
36. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy. Yan H, Wang R, Zhao F, Zhu K, Jiang S, Zhao W, Feng R. Acta Radiol; 2011 Jul 01; 52(6):646-50. PubMed ID: 21508201 [Abstract] [Full Text] [Related]
37. Prognostic value of 18-FDG uptake in early stage NSCLC. Chen JC, Huang TW, Cheng YL, Chang H, Tzao C, Huang WS, Lee SC. Thorac Cardiovasc Surg; 2009 Oct 01; 57(7):413-6. PubMed ID: 19795329 [Abstract] [Full Text] [Related]
38. Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer. Li M, Wu N, Zheng R, Liang Y, Liu Y, Zhang W, Li N, Zhao P. Cancer Imaging; 2013 Feb 07; 12(3):566-72. PubMed ID: 23399986 [Abstract] [Full Text] [Related]
39. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer. Zhang H, Wroblewski K, Pu Y. Acta Radiol; 2012 Jun 01; 53(5):561-8. PubMed ID: 22661603 [Abstract] [Full Text] [Related]
40. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM. Dis Esophagus; 2017 Aug 01; 30(8):1-10. PubMed ID: 28575243 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]